State Of Alaska, Department Of Revenue Ionis Pharmaceuticals Inc Transaction History

State Of Alaska, Department Of Revenue

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 02, 2019	SELL	$59.06 - $72.15 $863,339 - $1.05 Million	-14,618 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$62.09 - $86.14 $3,228 - $4,479	52 Added 0.36%	14,618 $939,000
Q1 2019 Apr 09, 2019	SELL	$52.92 - $81.17 $44,452 - $68,182	-840 Reduced 5.45%	14,566 $1.18 Million
Q4 2018 Jan 10, 2019	BUY	$43.37 - $59.54 $4,770 - $6,549	110 Added 0.72%	15,406 $832,000
Q3 2018 Oct 09, 2018	BUY	$42.88 - $53.7 $11,406 - $14,284	266 Added 1.77%	15,296 $788,000
Q2 2018 Jul 10, 2018	BUY	$40.53 - $50.7 $148,745 - $186,069	3,670 Added 32.31%	15,030 $626,000
Q1 2018 Apr 19, 2018	BUY	$44.08 - $55.05 $99,620 - $124,413	2,260 Added 24.84%	11,360 $500,000
Q4 2017 Jan 19, 2018	BUY	$50.3 - $64.39 $457,730 - $585,949	9,100	9,100 $457,000

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.